Copy Link Print Information

Avibactam sodium hydrate

(Synonyms: NXL-104 hydrate)
94 Cited Publications
Customer Review

Based on 94 publication(s) in Google Scholar

Avibactam sodium (NXL-104) hydrate is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively.

For research use only. We do not sell to patients.

  • Purity: 99.61%
  • CAS No.: 2938989-90-1
  • Formula: C7H12N3NaO7S
  • Molecular Weight:305.24
  • Storage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Avibactam sodium hydrate Chemical Structure
    Avibactam sodium hydrate Chemical Structure
  • Experimental Validation Results for Avibactam sodium hydrate
  • Experimental Validation Results for Avibactam sodium hydrate
  • Experimental Validation Results for Avibactam sodium hydrate
  • Experimental Validation Results for Avibactam sodium hydrate
  • Experimental Validation Results for Avibactam sodium hydrate
  • Experimental Validation Results for Avibactam sodium hydrate
  • Experimental Validation Results for Avibactam sodium hydrate
CAS No.: 2938989-90-1
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Avibactam sodium hydrate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Avibactam sodium hydrate

More
Customer Validation & Images
Bio/Physico-chemical AssayRT-PCRIn Vivo Efficacy StudyWBCell Proliferation/Viability Assay
  • RT-PCR
  • WB
  • WB
  • In Vivo Efficacy Study
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay
  • Cell Proliferation/Viability Assay

All Beta-lactamase Isoforms

More

All Antibiotic Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Avibactam sodium hydrate Chemical Structure
    Avibactam sodium hydrate Chemical Structure
    1/16
  • 1/16

    Avibactam sodium hydrate purchased from MedChemExpress. Usage Cited in: Cell Rep. 2024 Nov 9;43(11):114962. [Abstract]

    Customer Validation
     SREBP2 target gene transcript levels after treatment with Avibactam (0.69 μM, 24 h) analyzed by qPCR. Actin Beta (ACTB) was used as a reference gene.

  • 1/16

    Avibactam sodium hydrate purchased from MedChemExpress. Usage Cited in: Cell Rep. 2024 Nov 9;43(11):114962. [Abstract]

    Customer Validation
     S-acylation levels of SCAP in Huh7 cells treated with Avibactam (0.69 μM, 24 h).

  • 1/16

    Avibactam sodium hydrate purchased from MedChemExpress. Usage Cited in: Cell Rep. 2024 Nov 9;43(11):114962. [Abstract]

    Customer Validation
     Protein levels of SCAP and its downstream target proteins in Huh7 cells following treatment with Avibactam (0.69 μM, 24 h).

  • 1/16

    Avibactam sodium hydrate purchased from MedChemExpress. Usage Cited in: J Antimicrob Chemother. 2022 Sep 30;77(10):2803-2808. [Abstract]

    Customer Validation
     In vivo change in log10 cfu/thigh of each isolate treated with saline control, Ceftazidime 2 g IV q8h 2 h infusion HSR, Ceftazidime/Avibactam 2.5 g q8h 2 h infusion HSR or meropenem 2 g q8h 3 h infusion HSR for three P. aeruginosa with inserted GES β-lactamases. (a) PSA 2136, with inserted GES-1 (ESBL). (b) PSA 2137, with inserted GES-5 (carbapenemase). (c) PSA 2138, with inserted GES-15. P values in the boxes represent the results from one-way ANOVA; P values are presented if between-group differences were present. The x-axis describes the treatment HSR [MIC (mg/L), % fT>MIC]. CAZ, Ceftazidime; CAZ-AVI, Ceftazidime/Avibactam; MEM, meropenem.

  • 1/16

    Avibactam sodium hydrate purchased from MedChemExpress. Usage Cited in: Biosens Bioelectron. 2021 Dec 1:193:113526. [Abstract]

    Customer Validation
     Avibactam sodium (AVI: 6.3-50 mg/L) in the presence or absence of 200 mg/L ceftriaxone and/or 0.8 U/L CTX-M-14.

  • 1/16

    Avibactam sodium hydrate purchased from MedChemExpress. Usage Cited in: Biosens Bioelectron. 2021 Dec 1:193:113526. [Abstract]

    Customer Validation
     Analysis of mixed mock samples containing 0.8 U/L each of NDM-1/CTX-M-14 were incubated with penicillin, ceftriaxone, cefepime, cefoxitin or meropenem (200 mg/L) in the presence and absence of 25 mg/L Avibactam sodium (AVI) for 15 min, then the NDM-1/CTX-M-14 treated and untreated antibiotic samples were analyzed.

  • 1/16

    Avibactam sodium hydrate purchased from MedChemExpress. Usage Cited in: J Antimicrob Chemother. 2017 Jul 1;72(7):1930-1936. [Abstract]

    Customer Validation
     Total β-lactamase activity for bacterial lysates is measured using the chromogenic substrate nitrocefin, with or without Avibactam at 4 mg/L. (b) GR20263 hydrolysis activity of different bacterial lysates is determined with or without Avibactam at 4 mg/L.

  • Avibactam sodium hydrate